China National Accord Medicines Corporation Ltd. (SHE:000028)
China flag China · Delayed Price · Currency is CNY
21.09
-0.11 (-0.52%)
Nov 17, 2026, 3:04 PM CST

SHE:000028 Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, SHE:000028 stock has a consensus rating of "Buy" and an average price target of ¥24.33. The average 1-year stock price forecast is 15.36% higher than the current stock price, while the lowest is ¥17.50 (-17.02%) and the highest is ¥29.00 (+37.51%).

Price Target: ¥24.33 (+15.36%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥17.50¥24.33¥25.42¥29.00
Change-17.02%+15.36%+20.53%+37.51%

Analyst Ratings

The average analyst rating for SHE:000028 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy222222
Buy111111
Hold000000
Sell000000
Strong Sell211111
Total544444

Financial Forecast

Revenue This Year
74.82B
from 73.42B
Increased by 1.91%
Revenue Next Year
78.63B
from 74.82B
Increased by 5.10%
EPS This Year
2.35
from 1.79
Increased by 31.11%
EPS Next Year
2.55
from 2.35
Increased by 8.53%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
68.36B73.44B75.48B74.38B73.42B74.82B
Revenue Growth
14.60%7.44%2.77%-1.46%-1.29%1.91%
Gross Profit
7.99B8.88B9.01B8.20B7.80B7.68B
Gross Margin
11.68%12.09%11.93%11.02%10.62%10.27%
Operating Income
2.03B2.30B2.41B1.56B1.72B1.85B
Net Income
1.34B1.49B1.60B642.49M1.14B1.17B
EPS
----1.792.35
EPS Growth
----89.15%31.11%
Forward PE
10.1310.1410.1016.4310.368.99
Dividend / Share
0.420.560.620.330.560.58
Dividend Growth
-24.99%33.34%10.49%-46.18%68.32%3.57%
Free Cash Flow
-----2.22B
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High74.8B
Avg74.8B
Low74.8B

Revenue Growth

Revenue Growth202620272028
High
1.9%
Avg
1.9%
Low
1.9%

EPS Forecast

EPS202620272028
High2.35
Avg2.35
Low2.35

EPS Growth

EPS Growth202620272028
High
31.1%
Avg
31.1%
Low
31.1%